Table: Kaken Pharmaceutical -Q1 group results

KAKEN PHARMACEUTICAL

07/08/2026 07:35

    Aug 7 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             30.15               18.87            89.90    
                 (+59.8 pct)         (+3.4 pct)       (+17.0 pct) 
  Operating         10.90              14 mln             7.90    
                                     (-99.5 pct)                  
  Recurring         11.26              417 mln            8.60    
                                     (-86.1 pct)                  
  Net                8.44              271 mln            6.50    
                                     (-84.5 pct)     (+203.1 pct) 
  EPS            222.86 yen           7.13 yen        171.65 yen  
  Ann Div                            190.00 yen       190.00 yen  
  -Q2 div                             95.00 yen        95.00 yen  
  -Q4 div                             95.00 yen        95.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T